ADOCIA : Information relative au nombre d'actions et de droits de vote en date du 28 février 2025
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 14 2025
0mins
Source: Businesswire
Company Overview: Adocia SA is a clinical-stage biopharmaceutical company based in Lyon, specializing in innovative therapeutic solutions for diabetes and obesity, with a diverse portfolio of drug candidates developed through proprietary technologies.
Shareholder Information: As of February 28, 2025, Adocia has 18,084,200 shares outstanding and 20,218,939 theoretical voting rights, with recent issuance of 120,000 shares as part of a financing line, which has since been terminated.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
